Research Article

An Investigation into the Use and Meaning of Parkinson’s Disease Clinical Scale Scores

Table 1

A summary of the UPDRS limitations [58].

Accuracy unknownUneven in type of information gathered

SubjectiveContain redundancies in sections
Numerically nonlinearChoice selections and section constructs differ
Ordinal scale with score meaning, level, differences, and divisions unknownUPDRS Part II considered culturally biased
Unable to discriminate between disease categories of clinical relevanceApplicable to most, but not all, international urban settings
Scores cannot differentiate nor compare patientsEffects of age, gender, race, and ethnicity on ratings have not been examined
All score sections not reportedLimited utility in early disease stages
Completed in a limited timeframe (clinic visit)Can be affected by prior patient activities, but not recorded
Questions difficult to read and understand, responses based on interpretation by rater and patientNo connection to clinical stages
Differences exist among interrater reliabilitiesInadequate instructions for raters
Based on physician’s experience, inexperienceRespondents may not answer appropriately, fear of score outcome, lower total scores
Anxiety, sleep disorders, fatigue, urinary disfunction, other symptoms not includedNonmotor symptoms not clinically diagnosed
How to track comorbidities does not existCannot be used as a severity measure of any behavior